{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:20:57Z","timestamp":1793067657953,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mabwell Therapeutics Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03733-2","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:36:38Z","timestamp":1771853798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A ligand-mimetic anti-TREM2 agonist antibody elevates soluble TREM2 and ameliorates pathology in mouse models of Alzheimer\u2019s disease and multiple sclerosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Buxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Chung","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"6005","key":"3733_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841\u20135.","journal-title":"Science"},{"issue":"1","key":"3733_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2015.06.012","volume":"43","author":"J Bruttger","year":"2015","unstructured":"Bruttger J, Karram K, Wortge S, Regen T, Marini F, Hoppmann N, et al. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity. 2015;43(1):92\u2013106.","journal-title":"Immunity"},{"issue":"1","key":"3733_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2009.05.006","volume":"17","author":"I Yang","year":"2010","unstructured":"Yang I, Han SJ, Kaur G, Crane C, Parsa AT. The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci. 2010;17(1):6\u201310.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"3733_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/1673-5374.322423","volume":"17","author":"J Cornell","year":"2022","unstructured":"Cornell J, Salinas S, Huang HY, Zhou M. Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res. 2022;17(4):705\u201316.","journal-title":"Neural Regen Res"},{"issue":"2","key":"3733_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.devcel.2016.07.006","volume":"38","author":"S Hong","year":"2016","unstructured":"Hong S, Stevens B. Microglia: phagocytosing to clear, sculpt, and eliminate. Dev Cell. 2016;38(2):126\u20138.","journal-title":"Dev Cell"},{"issue":"8","key":"3733_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tcb.2016.02.006","volume":"26","author":"JL Frost","year":"2016","unstructured":"Frost JL, Schafer DP. Microglia: architects of the developing nervous system. Trends Cell Biol. 2016;26(8):587\u201397.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"3733_CR7","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H. Loss of \u201chomeostatic\u201d microglia and patterns of their activation in active multiple sclerosis. Brain. 2017;140(7):1900\u201313.","journal-title":"Brain"},{"issue":"7434","key":"3733_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"7685","key":"3733_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer\u2019s disease. Nature. 2017;552(7685):355\u201361.","journal-title":"Nature"},{"issue":"7","key":"3733_CR10","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-90 e17.","journal-title":"Cell"},{"issue":"3","key":"3733_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566-81 e9.","journal-title":"Immunity"},{"issue":"3","key":"3733_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.cell.2019.05.056","volume":"178","author":"BL Heckmann","year":"2019","unstructured":"Heckmann BL, Teubner BJW, Tummers B, Boada-Romero E, Harris L, Yang M, et al. LC3-Associated endocytosis facilitates beta-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s disease. Cell. 2019;178(3):536-51 e14.","journal-title":"Cell"},{"issue":"1","key":"3733_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.nbd.2004.09.019","volume":"18","author":"MR Kotter","year":"2005","unstructured":"Kotter MR, Zhao C, van Rooijen N, Franklin RJ. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis. 2005;18(1):166\u201375.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"3733_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 2020;181(6):1207\u201317.","journal-title":"Cell"},{"issue":"1","key":"3733_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):66.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"3733_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell. 2017;170(4):649-63 e13.","journal-title":"Cell"},{"issue":"1","key":"3733_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40478-024-01855-3","volume":"12","author":"TJ McCray","year":"2024","unstructured":"McCray TJ, Bedford LM, Bissel SJ, Lamb BT. Trem2-deficiency aggravates and accelerates age-related myelin degeneration. Acta Neuropathol Commun. 2024;12(1):154.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"3733_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90(4):724\u201339.","journal-title":"Neuron"},{"issue":"1","key":"3733_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, McCray TJ, Allan K, Formica SV, Xu G, Wilson G, et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener. 2017;12(1):74.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"3733_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12974-022-02671-z","volume":"20","author":"N Beckmann","year":"2023","unstructured":"Beckmann N, Neuhaus A, Zurbruegg S, Volkmer P, Patino C, Joller S, et al. Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model. J Neuroinflammation. 2023;20(1):29.","journal-title":"J Neuroinflammation"},{"key":"3733_CR21","doi-asserted-by":"crossref","unstructured":"Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, et al. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med. 2022;219(12):e20212479.","DOI":"10.1084\/jem.20212479"},{"issue":"5","key":"3733_CR22","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1172\/JCI77983","volume":"125","author":"PL Poliani","year":"2015","unstructured":"Poliani PL, Wang Y, Fontana E, Robinette ML, Yamanishi Y, Gilfillan S, et al. TREM2 sustains microglial expansion during aging and response to demyelination. J Clin Invest. 2015;125(5):2161\u201370.","journal-title":"J Clin Invest"},{"issue":"5","key":"3733_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/eji.200636837","volume":"37","author":"L Piccio","year":"2007","unstructured":"Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol. 2007;37(5):1290\u2013301.","journal-title":"Eur J Immunol"},{"issue":"1","key":"3733_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng-Hathaway","year":"2018","unstructured":"Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, et al. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):29.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"3733_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"3733_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"key":"3733_CR27","doi-asserted-by":"crossref","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model. J Exp Med. 2020;217(9):e20200785.","DOI":"10.1084\/jem.20200785"},{"issue":"1","key":"3733_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, et al. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation. 2020;17(1):238.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3733_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","volume":"140","author":"F Cignarella","year":"2020","unstructured":"Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 2020;140(4):513\u201334.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3733_CR30","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12(4):e11227.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"3733_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.15252\/emmm.201707673","volume":"9","author":"P Thornton","year":"2017","unstructured":"Thornton P, Sevalle J, Deery MJ, Fraser G, Zhou Y, Stahl S, et al. TREM2 shedding by cleavage at the H157\u2013S158 bond is accelerated for the Alzheimer\u2019s disease-associated H157Y variant. EMBO Mol Med. 2017;9(10):1366\u201378.","journal-title":"EMBO Mol Med"},{"key":"3733_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","volume":"660","author":"D Feuerbach","year":"2017","unstructured":"Feuerbach D, Schindler P, Barske C, Joller S, Beng-Louka E, Worringer KA, et al. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neurosci Lett. 2017;660:109\u201314.","journal-title":"Neurosci Lett"},{"issue":"10","key":"3733_CR33","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow K, Kleinberger G, Fukumori A, Feederle R, Lichtenthaler SF, Steiner H, et al. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol Med. 2017;9(10):1356\u201365.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"3733_CR34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Suarez-Calvet","year":"2016","unstructured":"Suarez-Calvet M, Kleinberger G, Araque Caballero MA, Brendel M, Rominger A, Alcolea D, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8(5):466\u201376.","journal-title":"EMBO Mol Med"},{"key":"3733_CR35","doi-asserted-by":"crossref","unstructured":"Ewers M, Franzmeier N, Suarez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Sci Transl Med. 2019;11(507):eaav6221.","DOI":"10.1126\/scitranslmed.aav6221"},{"issue":"1","key":"3733_CR36","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","volume":"10","author":"L Zhong","year":"2019","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model. Nat Commun. 2019;10(1):1365.","journal-title":"Nat Commun"},{"issue":"1","key":"3733_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12974-021-02340-7","volume":"18","author":"X Sheng","year":"2021","unstructured":"Sheng X, Yao Y, Huang R, Xu Y, Zhu Y, Chen L, et al. Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology. J Neuroinflammation. 2021;18(1):286.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3733_CR38","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41467-023-42505-x","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang L, Yang J, Meng L, Chen J, Zhou L, et al. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease. Nat Commun. 2023;14(1):6670.","journal-title":"Nat Commun"},{"issue":"9","key":"3733_CR39","doi-asserted-by":"publisher","first-page":"110883","DOI":"10.1016\/j.celrep.2022.110883","volume":"39","author":"R Dhandapani","year":"2022","unstructured":"Dhandapani R, Neri M, Bernhard M, Brzak I, Schweizer T, Rudin S, et al. Sustained Trem2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer\u2019s disease. Cell Rep. 2022;39(9):110883.","journal-title":"Cell Rep"},{"key":"3733_CR40","doi-asserted-by":"crossref","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM. Chronic TREM2 activation exacerbates Abeta-associated tau seeding and spreading. J Exp Med. 2023;220(1):e20220654.","DOI":"10.1084\/jem.20220654"},{"issue":"43","key":"3733_CR41","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1523\/JNEUROSCI.1238-16.2016","volume":"36","author":"M Kobayashi","year":"2016","unstructured":"Kobayashi M, Konishi H, Sayo A, Takai T, Kiyama H. TREM2\/DAP12 signal elicits proinflammatory response in microglia and exacerbates neuropathic pain. J Neurosci. 2016;36(43):11138\u201350.","journal-title":"J Neurosci"},{"issue":"40","key":"3733_CR42","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"1","key":"3733_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/jmbi.1997.1116","volume":"270","author":"S Atwell","year":"1997","unstructured":"Atwell S, Ridgway JB, Wells JA, Carter P. Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J Mol Biol. 1997;270(1):26\u201335.","journal-title":"J Mol Biol"},{"issue":"7","key":"3733_CR44","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/protein\/9.7.617","volume":"9","author":"JB Ridgway","year":"1996","unstructured":"Ridgway JB, Presta LG, Carter P. \u201cKnobs-into-holes\u201d engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 1996;9(7):617\u201321.","journal-title":"Protein Eng"},{"issue":"4","key":"3733_CR45","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/19420862.2016.1160192","volume":"8","author":"AD Tustian","year":"2016","unstructured":"Tustian AD, Endicott C, Adams B, Mattila J, Bak H. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity. MAbs. 2016;8(4):828\u201338.","journal-title":"MAbs"},{"issue":"6","key":"3733_CR46","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.14283\/jpad.2024.164","volume":"11","author":"M Lin","year":"2024","unstructured":"Lin M, Yu JX, Zhang WX, Lao FX, Huang HC. Roles of TREM2 in the pathological mechanism and the therapeutic strategies of Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2024;11(6):1682\u201395.","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"3733_CR47","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.R115.704981","volume":"291","author":"J Walter","year":"2016","unstructured":"Walter J. The Triggering Receptor Expressed on Myeloid Cells 2: a molecular link of neuroinflammation and neurodegenerative diseases. J Biol Chem. 2016;291(9):4334\u201341.","journal-title":"J Biol Chem"},{"issue":"1","key":"3733_CR48","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1038\/s41598-017-11634-x","volume":"7","author":"SM Kim","year":"2017","unstructured":"Kim SM, Mun BR, Lee SJ, Joh Y, Lee HY, Ji KY, et al. TREM2 promotes Abeta phagocytosis by upregulating C\/EBPalpha-dependent CD36 expression in microglia. Sci Rep. 2017;7(1):11118.","journal-title":"Sci Rep"},{"issue":"5","key":"3733_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"108","author":"JW Lewcock","year":"2020","unstructured":"Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C. Emerging microglia biology defines novel therapeutic approaches for Alzheimer\u2019s disease. Neuron. 2020;108(5):801\u201321.","journal-title":"Neuron"},{"issue":"3","key":"3733_CR50","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, et al. A TREM2-activating antibody with a blood\u2013brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26(3):416\u201329.","journal-title":"Nat Neurosci"},{"issue":"2","key":"3733_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s42255-021-00341-7","volume":"3","author":"M Bosch-Queralt","year":"2021","unstructured":"Bosch-Queralt M, Cantuti-Castelvetri L, Damkou A, Schifferer M, Schlepckow K, Alexopoulos I, et al. Diet-dependent regulation of TGFbeta impairs reparative innate immune responses after demyelination. Nat Metab. 2021;3(2):211\u201327.","journal-title":"Nat Metab"},{"key":"3733_CR52","doi-asserted-by":"crossref","unstructured":"Zhao P, Xu Y, Fan X, Li L, Li X, Arase H, et al. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice. MAbs. 2022;14(1):2107971.","DOI":"10.1080\/19420862.2022.2107971"},{"issue":"661","key":"3733_CR53","doi-asserted-by":"publisher","first-page":"eabq0095","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(661):eabq0095.","journal-title":"Sci Transl Med"},{"key":"3733_CR54","doi-asserted-by":"crossref","unstructured":"Etxeberria A, Shen Y-AA, Vito S, Silverman SM, Imperio J, Lalehzadeh G, et al. Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer\u2019s disease and multiple sclerosis. J Neurosci. 2024;44(29):e2347232024.","DOI":"10.1523\/JNEUROSCI.2347-23.2024"},{"key":"3733_CR55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H. Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci. 2018;12:206.","journal-title":"Front Cell Neurosci"},{"key":"3733_CR56","doi-asserted-by":"crossref","unstructured":"Vilalta A, Zhou Y, Sevalle J, Griffin JK, Satoh K, Allendorf DH, et al. Wild-type sTREM2 blocks A\u03b2 aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases A\u03b2 aggregation. J Biol Chem 2021;296:100631.","DOI":"10.1016\/j.jbc.2021.100631"},{"issue":"8","key":"3733_CR57","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","volume":"56","author":"L Zhong","year":"2023","unstructured":"Zhong L, Sheng X, Wang W, Li Y, Zhuo R, Wang K, et al. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration. Immunity. 2023;56(8):1794-808 e8.","journal-title":"Immunity"},{"issue":"4","key":"3733_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodriguez","year":"2022","unstructured":"Morenas-Rodriguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suarez-Calvet M, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21(4):329\u201341.","journal-title":"Lancet Neurol"},{"key":"3733_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-024-00795-9","volume":"20","author":"JA Greven","year":"2025","unstructured":"Greven JA, Wydra JR, Greer RA, Zhi C, Price DA, Svoboda JD, et al. Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer\u2019s disease ligands. Mol Neurodegener. 2025;20:3.","journal-title":"Mol Neurodegener"},{"issue":"7948","key":"3733_CR60","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-022-05673-2","volume":"614","author":"X Yu","year":"2023","unstructured":"Yu X, Orr CM, Chan HTC, James S, Penfold CA, Kim J, et al. Reducing affinity as a strategy to boost immunomodulatory antibody agonism. Nature. 2023;614(7948):539\u201347.","journal-title":"Nature"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03733-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03733-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03733-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:01:32Z","timestamp":1777626092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03733-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3733"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03733-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted in accordance with the institutional guidelines and regulations for the care and use of research animals at the Charles River Accelerator and Development Laboratory (CRADL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are full-time employees of Mabwell Therapeutics, Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}